Carbylan Therapeutics Inc buy BiotechBee
Start price
04.02.24
/
60%
€14.10
Target price
31.03.26
€22.00
Performance (%)
-30.50%
Price
25.04.24
€9.80
Summary
This prediction is currently active. Massive losses of -30.50% have been the result for the BUY prediction by BiotechBee. This prediction currently runs until 31.03.26. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Carbylan Therapeutics Inc | -12.500% | -12.500% |
iShares Core DAX® | 2.594% | -1.861% |
iShares Nasdaq 100 | 3.553% | -2.064% |
iShares Nikkei 225® | 0.687% | -8.704% |
iShares S&P 500 | 2.209% | -1.988% |
According to BiotechBee what are the pros and cons of Carbylan Therapeutics Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Carbylan Therapeutics Inc diskutieren
Buy mit Kursziel 22,0
Stopped prediction by BiotechBee for Carbylan Therapeutics Inc
Carbylan Therapeutics Inc
Start price
Target price
Perf. (%)
€8.10
27.06.23
27.06.23
€12.00
31.07.26
31.07.26
74.07%
04.02.24
04.02.24
Could be very worthwhile Investment >20% year
Carbylan Therapeutics Inc
Start price
Target price
Perf. (%)
€6.60
03.01.23
03.01.23
€10.00
31.12.25
31.12.25
30.22%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year